{"id":107181,"date":"2021-02-16T14:36:50","date_gmt":"2021-02-16T14:36:50","guid":{"rendered":"https:\/\/fin2me.com\/?p=107181"},"modified":"2021-02-16T14:36:50","modified_gmt":"2021-02-16T14:36:50","slug":"india-to-multiply-vaccinations-amid-coverage-concerns","status":"publish","type":"post","link":"https:\/\/fin2me.com\/markets\/india-to-multiply-vaccinations-amid-coverage-concerns\/","title":{"rendered":"India to multiply vaccinations amid coverage concerns"},"content":{"rendered":"

NEW DELHI (Reuters) – India will increase the number of its COVID-19 vaccination sites by up to five times after administering nearly 9 million shots in a month, a government official said on Tuesday, amid concerns about the speed of coverage in the country.<\/p>

FILE PHOTO: A man receives a Bharat Biotech’s COVID-19 vaccine called COVAXIN, at a vaccination centre, in New Delhi, India, February 13, 2021. REUTERS\/Adnan Abidi<\/figcaption>

Having reported the highest number of coronavirus infections after the United States, and with the world\u2019s biggest vaccine-making capacity, India says it has been the fastest to reach many inoculation milestones.<\/p>\n

However it is vaccinating only around 300,000 front-line workers a day, a total that will have to increase sharply to meet the government\u2019s target of covering 300 million of its 1.35 billion people by August, experts say.<\/p>\n

The ongoing vaccination of front-line workers such as nurses and doctors has taught India how to scale up the campaign, Vinod Kumar Paul, who heads a government panel on vaccine strategy, told a news conference.<\/p>\n

\u201cThis learning will be of great use,\u201d he said, hours after taking the second dose of a government-backed vaccine. \u201cWe are currently running 10,000-11,000 immunisation sessions. We will do four to five times of that when we start the next phase; wait for the pace to pick up.\u201d<\/p>\n

India will begin immunising the public from next month, starting with those over 50 or with medical conditions.<\/p>\n

The country has covered 60% of its nearly 10 million healthcare workers since starting the drive on Jan. 16, though as many as 11 of its 36 states or federally controlled territories have not even reached the halfway mark.<\/p>\n

\u201cThese are not very unsatisfactory figures,\u201d Health Secretary Rajesh Bhushan said. \u201cWe agree that like in any other field, there is a scope for improvement.\u201d<\/p>\n

India is using a home-grown vaccine developed by Bharat Biotech and the state-run Indian Council of Medical Research, and another licensed from AstraZeneca and Oxford University. Other vaccines are in the queue, including Russia\u2019s Sputnik V and products from Cadila Healthcare, Novavax and Johnson & Johnson.<\/p>\n

India, which makes 60% of the world\u2019s vaccines, has also exported COVID-19 shots to 24 countries as part of a diplomatic push.<\/p>\n

Some Indians, however, wonder why the government is not expanding coverage at home when it has shipped 17 million doses – including around 6 million as gifts to partners such as Bangladesh and Nepal. For its own campaign, New Delhi has so far only ordered 31 million doses.<\/p>\n

\u201cI love my neighbours and friends, but should I love them at my expense (literally) and to my detriment?\u201d Happymon Jacob, who teaches diplomacy at New Delhi\u2019s Jawaharlal Nehru University, said on Twitter.<\/p>\n

India\u2019s COVID-19 cases rose by 9,121 in the past 24 hours, taking the total to 10.93 million. Deaths rose by 81 to 155,813.<\/p>\n

Source: Read Full Article<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

NEW DELHI (Reuters) – India will increase the number of its COVID-19 vaccination sites by up to five times after administering nearly 9 million shots […]<\/p>\n","protected":false},"author":3,"featured_media":107180,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"yoast_head":"\nIndia to multiply vaccinations amid coverage concerns - Fin2me<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fin2me.com\/markets\/india-to-multiply-vaccinations-amid-coverage-concerns\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"India to multiply vaccinations amid coverage concerns - Fin2me\" \/>\n<meta property=\"og:description\" content=\"NEW DELHI (Reuters) – India will increase the number of its COVID-19 vaccination sites by up to five times after administering nearly 9 million shots [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fin2me.com\/markets\/india-to-multiply-vaccinations-amid-coverage-concerns\/\" \/>\n<meta property=\"og:site_name\" content=\"Fin2me\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-16T14:36:50+00:00\" \/>\n<meta name=\"author\" content=\"Mark\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/fin2me.com\/wp-content\/uploads\/2021\/02\/cnewsfotor19.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fin2me.com\/markets\/india-to-multiply-vaccinations-amid-coverage-concerns\/\",\"url\":\"https:\/\/fin2me.com\/markets\/india-to-multiply-vaccinations-amid-coverage-concerns\/\",\"name\":\"India to multiply vaccinations amid coverage concerns - Fin2me\",\"isPartOf\":{\"@id\":\"https:\/\/fin2me.com\/#website\"},\"datePublished\":\"2021-02-16T14:36:50+00:00\",\"dateModified\":\"2021-02-16T14:36:50+00:00\",\"author\":{\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\"},\"breadcrumb\":{\"@id\":\"https:\/\/fin2me.com\/markets\/india-to-multiply-vaccinations-amid-coverage-concerns\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fin2me.com\/markets\/india-to-multiply-vaccinations-amid-coverage-concerns\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fin2me.com\/markets\/india-to-multiply-vaccinations-amid-coverage-concerns\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/fin2me.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Markets\",\"item\":\"https:\/\/fin2me.com\/category\/markets\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"India to multiply vaccinations amid coverage concerns\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fin2me.com\/#website\",\"url\":\"https:\/\/fin2me.com\/\",\"name\":\"Fin2me\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fin2me.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\",\"name\":\"Mark\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"caption\":\"Mark\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"India to multiply vaccinations amid coverage concerns - Fin2me","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fin2me.com\/markets\/india-to-multiply-vaccinations-amid-coverage-concerns\/","og_locale":"en_US","og_type":"article","og_title":"India to multiply vaccinations amid coverage concerns - Fin2me","og_description":"NEW DELHI (Reuters) – India will increase the number of its COVID-19 vaccination sites by up to five times after administering nearly 9 million shots [...]","og_url":"https:\/\/fin2me.com\/markets\/india-to-multiply-vaccinations-amid-coverage-concerns\/","og_site_name":"Fin2me","article_published_time":"2021-02-16T14:36:50+00:00","author":"Mark","twitter_card":"summary_large_image","twitter_image":"https:\/\/fin2me.com\/wp-content\/uploads\/2021\/02\/cnewsfotor19.jpg","twitter_misc":{"Written by":"Mark","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fin2me.com\/markets\/india-to-multiply-vaccinations-amid-coverage-concerns\/","url":"https:\/\/fin2me.com\/markets\/india-to-multiply-vaccinations-amid-coverage-concerns\/","name":"India to multiply vaccinations amid coverage concerns - Fin2me","isPartOf":{"@id":"https:\/\/fin2me.com\/#website"},"datePublished":"2021-02-16T14:36:50+00:00","dateModified":"2021-02-16T14:36:50+00:00","author":{"@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a"},"breadcrumb":{"@id":"https:\/\/fin2me.com\/markets\/india-to-multiply-vaccinations-amid-coverage-concerns\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fin2me.com\/markets\/india-to-multiply-vaccinations-amid-coverage-concerns\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fin2me.com\/markets\/india-to-multiply-vaccinations-amid-coverage-concerns\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fin2me.com\/"},{"@type":"ListItem","position":2,"name":"Markets","item":"https:\/\/fin2me.com\/category\/markets\/"},{"@type":"ListItem","position":3,"name":"India to multiply vaccinations amid coverage concerns"}]},{"@type":"WebSite","@id":"https:\/\/fin2me.com\/#website","url":"https:\/\/fin2me.com\/","name":"Fin2me","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fin2me.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a","name":"Mark","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fin2me.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","caption":"Mark"}}]}},"_links":{"self":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/107181"}],"collection":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/comments?post=107181"}],"version-history":[{"count":0,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/107181\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media\/107180"}],"wp:attachment":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media?parent=107181"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/categories?post=107181"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/tags?post=107181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}